Diagnosis and management of exacerbations and acute respiratory failure in patients with chronic obstructive pulmonary disease;Exacerbations et décompensations de la bronchopneumopathie chronique obstructive

Revue du Praticien

Volumn 54, Issue 13, 2004, Pages 1438-1444

  Similowski, Thomas ^b   Cracco, Christophe ^b   Duguet, Alexandre ^b   Derenne, Jean Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; INFLUENZA VACCINE;

ACUTE RESPIRATORY FAILURE; ANTIBIOTIC THERAPY; BRONCHODILATATION; CHEST WALL OSCILLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MEDICAL DECISION MAKING; OXYGEN THERAPY; REVIEW; SMOKING CESSATION;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; BRONCHODILATOR AGENTS; DIAGNOSIS, DIFFERENTIAL; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; RESPIRATORY THERAPY; SMOKING CESSATION;

EID: 4544349090     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Société de pneumologie de langue française. Recommandations pour la prise en charge de la BPCO: actualisation 2003. Rev Mal Respir 2003; 20: 4S5-4S68.
2. Société de pneumologie de langue française. Recommandations pour la prise en charge de la BPCO: actualisation 2003; points essentiels version médecine générale. Presse Med, 2003; 32: 1188-94.
3. Pauwels R, Calverley P, Buist AS et al. COPD exacerbations: the importance of a standard definition. Respir Med 2004; 98: 99-107.
4. Mispelaere D, Glerant JC, Audebert M, Remond A, Sevestre-Pietri MA, Jounieaux V. Embolie pulmonaire et formes sibilantes des décompensations de bronchopneumopathie chronique obstructive. Rev Mal Respir 2002; 19: 415-23.
5. McCrory DC, Brown CD. Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library, Issue 3, 2003. Oxford: Update Software Ltd.
6. Cotton MM, Bucknall CE, Dagg KD et al. Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Thorax 2000; 55: 902-6.
7. Lightowler JV, Wedzicha JA, Mark W Elliott MW, Ram FSF. Non invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003; 326: 185-9.
8. Perrier A. L'essai randomisé-contrôlé: un guide de lecture. Rev Mal Respir 2002; 19: 505-14.
9. Wood-Baker R, Walters E, Gibson P. Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library, Issue 3, 2003. Oxford: Update Software Ltd.
10. Schols AM, Wesseling G, Kester AD et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001; 17: 337-42.
11. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001; 164: 358-64.
12. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52.
13. Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library, Issue 3, 2003. Oxford: Update Software Ltd.